Acumed

Acumed

Madrid, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Acumed is a well-established, commercial-stage medical device company with over 35 years of experience in the orthopedic trauma market. It has achieved significant commercial scale with flagship products like the Acutrak headless compression screw system (over 3 million implanted) and the Acu-Loc plating system (over 1 million plates placed). The company differentiates itself through a strong focus on surgeon education via its mobile cadaver lab program and is expanding into digital surgery with patient-tailored planning and implants. Acumed operates as a global business, with a headquarters in Madrid, Spain, and a significant operational presence in the United States.

Orthopedic TraumaExtremity SurgeryCraniomaxillofacial (CMF)

Technology Platform

Portfolio of mechanical fracture fixation implants (plates, screws, nails, staples) and instrumentation, complemented by a digital surgery platform for patient-specific planning and implants, and a mobile cadaver lab service for surgeon training.

Opportunities

The global shift of orthopedic procedures to Ambulatory Surgical Centers (ASCs) presents a major growth channel for Acumed's extremity-focused portfolio.
Furthermore, the integration of its digital surgery platform allows it to compete in the high-growth, value-based segment of personalized implants and complex case management, moving beyond standard hardware.

Risk Factors

Acumed faces intense competition from much larger, diversified orthopedic giants with greater commercial resources.
Its growth is also susceptible to global healthcare cost-containment pressures, which could lead to pricing erosion for its implant systems, and regulatory hurdles for its digital and new device offerings.

Competitive Landscape

Acumed competes in the orthopedic trauma space against massive, full-portfolio companies like Stryker (Trauma & Extremities), DePuy Synthes (J&J), and Zimmer Biomet. Its differentiation lies in its deep specialization in extremities, a strong focus on surgeon education via its unique mobile labs, and a targeted portfolio that avoids direct competition in large-joint reconstruction. It also competes with other extremity specialists like Arthrex, Orthofix, and Wright Medical (now part of Stryker).